G. Verleden (Leuven, Belgium), J. Gottlieb (Hanover, Germany)
NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation
U. Sommerwerck, M. Lindemann, B. E. Kleibrink, T. Rabis, G. Weinreich, M. Kamler, H. Teschler, P. A. Horn, V. Rebmann (Essen, Germany)
|  |
Epidermal growth factor receptor expression in human lung transplantation
B. Renaud-Picard, T. Degot, D. Biondini, M. Beau-Faller, T. Lavaux, N. Santelmo, S. Hirschi, R. Kessler (Strasbourg, France)
| |
Interactive plasticity of alveolar macrophages and microbiota in lung transplant recipient
E. Bernasconi, A. Koutsokera, D. Dumas, C. Pattaroni, B. Camara, B. J. Marsland, C. Benden, C. Pison, J. D. Aubert, L. P. Nicod (Lausanne, Zurich, Switzerland; Grenoble, Lyon, France)
|  |
A case series of fidaxomicin for treatment of Clostridium difficile infection (CDI) in lung transplant (LTx) recipients
T. Welte (Hannover, Germany)
| |
Non-tuberculous mycobacterium infection in lung transplant recipients
H. E. Riera Ave, C. Bravo, B. Sáez, T. Tórtola, F. Ruiz, C. Berastegui, M. Lopez Meseguer, V. Monforte, A. Román (Barcelona, Madrid, Spain)
| |
Severe infection due to corynebacterium striatum or amycolatum in 6 lung transplanted patients
A. C. Métivier, N. Grall, G. Dauriat, O. Brugière, H. Mal (Paris, France)
| |
Posaconazole levels in the bronchoalveolar lavage from lung transplant recipients
L. Thakuria, K. Packwood, S. Soresi, K. Habibi-Parker, H. Lyster, H. Lamba, A. Firouzi, P. Rogers, M. Chibvuri, M. Carby, A. Simon, N. Leaver, A. Reed (Harefield, Hoddesdon, United Kingdom)
| |
Viral infection land lung function decline following lung transplantation
K. Jahn, P. Grendelmeier, J. D. Aubert, H. Hirsch, D. Stolz, M. Tamm (Basel, Lausanne, Switzerland)
| |
Fungal re-colonization in cystic fibrosis or bronchiectasis patients after lung transplantation: Incidence, time of onset and related-factors
E. Abraham, E. Blanchard, C. Raherison, M. Tunon de Lara, J. Jougon, H. Roze, R. Veillon, A. Messadi, C. Dromer (Bordeaux, France)
| |
Risk factors and outcomes of airway complications after lung transplant in the Portuguese Center
A. S. Santos, R. Coelho, R. Rosa, D. Maia, T. Sá, V. Caldeira, A. Borba, I. Bravio, F. Martelo, L. Semedo, J. Fragata, J. Cardoso (Lisboa, Portugal)
| |
Anastomotic airway complications after lung transplantation: Risk factors, treatment modalities and outcome: A single center experience
J. Yserbyt, C. Dooms, R. Vos, L. Dupont, M. Decramer, D. Van Raemdonck, G. M. Verleden (Leuven, Belgium)
| |
Acinar ventilation heterogeneity (Sacin) assessed by nitrogen multiple breath washout is an accurate and sensitive marker of bronchiolitis obliterans (BO)
F. De Giacomi, M. T. Lupo-Stanghellini, A. Orsini, F. Ciceri, G. Cremona (Milan, Italy)
| |
Lung transplantation in systemic sclerosis: Experience in a spanish center
M. G. Silveira, A. Fernández Codina, C. Berastegui García, V. Monforte Ruiz, V. Fonollosa Pla, C. Pilar Simeon, A. Román Broto (Barcelona, Spain)
| |
Pirfenidone stabilizes pulmonary function and reduces 18F-FDG-uptake in restrictive allograft syndrome following lung transplantation
R. Vos, S. Verleden, D. Ruttens, E. Vandermeulen, H. Bellon, J. Yserbyt, L. Dupont, O. Gheysens, N. De Raedt, D. Van Raemdonck, B. Vanaudenaerde, G. Verleden (Leuven, Belgium)
| |
Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation
B. Sáez, C. Bravo, K. Loor, C. Berastegui, M. Lopez, V. Monforte, J. Giralt, L. Arbelaez, R. Antonio (Barcelona, Madrid, Spain)
| |
5 years follow-up of lung transplant recipients undergoing extracorporal photophoresis
L. C. Huber, U. Buergi, B. Isenring, E. Perret, M. Schuurmans, M. Kohler, G. Hofbauer, C. Benden (Zurich, Switzerland)
| |
Extracorporeal photopheresis in lung transplant:The initial experience in our hospital
M. Aguilar Pérez, M. T. Lazaro Carrasco de la Fuente, J. L. Bueno Cabrera, A. Morales de la Plaza, R. Laporta Hernandez, P. Ussetti Gil (Majadahonda, Spain)
| |